Replies to post #5146 on AVEO Pharmaceuticals, Inc. (AVEO)

[Biotech Pharmer]

It's already been re-assessed this year and green lighted until the next customary new drug re-assessment in 2020. Get with the program. https://www.ema.europa.eu/en/medicines/human/EPAR/fotivda